Drugmaker Merck to acquire Imago BioSciences for $1.35 bln – ET HealthWorld


0


Bengaluru: Merck & Co Inc said on Monday it would acquire cancer drug developer Imago BioSciences for a total equity value of $1.35 billion.

Merck’s offer of $36 per share in cash for Imago represents nearly a 107 per cent premium to the company’s last closing price.

The deal for the clinical-stage biopharmaceutical company that is developing drugs for the treatment of bone marrow-related diseases is expected to close in the first quarter of 2023, Merck said.

Follow and connect with us on , Facebook, Linkedin, Youtube





Source link


Like it? Share with your friends!

0
Shafiq

0 Comments

Your email address will not be published. Required fields are marked *